MENU

NEPH Stock Tickeron detected bullish Stock Pattern: Triangle Symmetrical Bottom NEPH on September 02, 2025, netting in a 8.19% gain over 2 weeks

A.I.dvisor
at Tickeron.com
Loading...
+8.19% Gain from a Successful pattern Triangle Symmetrical Bottom
NEPH - Nephros
Tickeron
Ticker: NEPH
Company: Nephros
Gain: +8.19%
Confirmed: 09/02/25
Succeeded: 09/15/25
Total length: 18 days
On August 28, 2025, A.I.dvisor detected a Triangle Symmetrical Bottom Pattern (Bullish) for Nephros (NEPH, $4.03). On September 02, 2025, A.I.dvisor confirmed the Bullish pattern, setting a target price of $4.60. 13 days later, on September 15, 2025, NEPH reached the target price resulting in a for traders who took a long position in the stock.

NEPH in upward trend: price rose above 50-day moving average on September 02, 2025

NEPH moved above its 50-day moving average on September 02, 2025 date and that indicates a change from a downward trend to an upward trend. In of 49 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NEPH advanced for three days, in of 202 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NEPH as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NEPH turned negative on September 18, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NEPH broke above its upper Bollinger Band on September 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NEPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.617) is normal, around the industry mean (10.726). P/E Ratio (34.833) is within average values for comparable stocks, (55.245). NEPH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.690). NEPH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (2.680) is also within normal values, averaging (13.843).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NEPH showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
380 Lackawanna Place
Phone
+1 201 343-5202
Employees
31
Web
https://www.nephros.com